$160 BN Pfizer/Allergen called deal off

That anticipated $160 billion merger has been called off between US
drugmaker Pfizer and Irish competitor Allergen.

According to Pfizer, the deal has fallen through over new US Treasury
rules, that aim to curb US tax evasion through mergers like this.

Mimi Chiahemen reports from New York

IN: "With the.."
OUT: SOC
DUR: 42 secs

AIR: http://www.fsnradionews.com/feeds/0406-allergenpfizer-mc-air.mp3
ARN: http://www.fsnradionews.com/feeds/0406-allergenpfizer-mc-arn.mp3
FM4: http://www.fsnradionews.com/feeds/0406-allergenpfizer-mc-fm4.mp3
GENERIC: http://www.fsnradionews.com/feeds/0406-allergenpfizer-mc-gen.mp3
ICRT: http://www.fsnradionews.com/feeds/0406-allergenpfizer-mc-icrt.mp3
NIGERIA: http://www.fsnradionews.com/feeds/0406-allergenpfizer-mc-von.mp3
RNZ: http://www.fsnradionews.com/feeds/0406-allergenpfizer-mc-rnz.mp3
SABC: http://www.fsnradionews.com/feeds/0406-allergenpfizer-mc-sabc.mp3
SRN: http://www.fsnradionews.com/feeds/0406-allergenpfizer-mc-srn.mp3
VATICAN: http://www.fsnradionews.com/feeds/0406-allergenpfizer-mc-vat.mp3
ZIZ: http://www.fsnradionews.com/feeds/0406-allergenpfizer-mc-ziz.mp3
938: http://www.fsnradionews.com/feeds/0406-allergenpfizer-mc-938.mp3